Literature DB >> 16226700

Cancer epigenetics is no Mickey Mouse.

Andrew P Feinberg1.   

Abstract

Epigenetic changes are the most common alterations in human cancer, but it has been difficult to sort out cause and effect from studies of human tumors. Several recent nonlethal mouse models implicate both hypomethylation and loss of imprinting (LOI) in tumor formation, including a paper in this issue of Cancer Cell showing that transient hypomethylation in ES cells causes LOI and liver and intestinal tumors (). Hypomethylation appears to be a critical determinant of cancer, affecting chromosomal stability and specific gene targets.

Entities:  

Mesh:

Year:  2005        PMID: 16226700     DOI: 10.1016/j.ccr.2005.09.014

Source DB:  PubMed          Journal:  Cancer Cell        ISSN: 1535-6108            Impact factor:   31.743


  8 in total

1.  Methylation status of NEUROG2 and NID2 improves the diagnosis of stage I NSCLC.

Authors:  Junfeng Geng; Jinfeng Sun; Qiang Lin; Jun Gu; Yangxing Zhao; Hongyu Zhang; Xu Feng; Yinghua He; Wei Wang; Xiaoyu Zhou; Jian Yu
Journal:  Oncol Lett       Date:  2012-02-01       Impact factor: 2.967

2.  Hypermethylation in bladder cancer: biological pathways and translational applications.

Authors:  Marta Sánchez-Carbayo
Journal:  Tumour Biol       Date:  2012-01-25

3.  Promoter-Specific Hypomethylation Is Associated with Overexpression of PLS3, GATA6, and TWIST1 in the Sezary Syndrome.

Authors:  Henry K Wong; Heather Gibson; Timothy Hake; Susan Geyer; Julie Frederickson; Guido Marcucci; Michael A Caligiuri; Pierluigi Porcu; Anjali Mishra
Journal:  J Invest Dermatol       Date:  2015-03-25       Impact factor: 8.551

Review 4.  Cancer epigenetics reaches mainstream oncology.

Authors:  Manuel Rodríguez-Paredes; Manel Esteller
Journal:  Nat Med       Date:  2011-03       Impact factor: 53.440

5.  WAMIDEX: a web atlas of murine genomic imprinting and differential expression.

Authors:  Reiner Schulz; Kathryn Woodfine; Trevelyan R Menheniott; Deborah Bourc'his; Timothy Bestor; Rebecca J Oakey
Journal:  Epigenetics       Date:  2008-03-18       Impact factor: 4.528

6.  Prognostic factors in oral and oropharyngeal cancer based on ultrastructural analysis and DNA methylation of the tumor and surgical margin.

Authors:  Daniela Mielcarek-Kuchta; Jarosław Paluszczak; Monika Seget; Katarzyna Kiwerska; Wiesława Biczysko; Krzysztof Szyfter; Witold Szyfter
Journal:  Tumour Biol       Date:  2014-05-01

Review 7.  Polyunsaturated fatty acids and DNA methylation in colorectal cancer.

Authors:  Mostafa Moradi Sarabi; Reza Mohammadrezaei Khorramabadi; Zohre Zare; Ebrahim Eftekhar
Journal:  World J Clin Cases       Date:  2019-12-26       Impact factor: 1.337

8.  Epigenetic therapy: use of agents targeting deacetylation and methylation in cancer management.

Authors:  Allen S Ho; Sevin Turcan; Timothy A Chan
Journal:  Onco Targets Ther       Date:  2013-03-21       Impact factor: 4.147

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.